In August 2025, the Centers for Disease Control and Prevention (CDC) shocked the U.S. healthcare community by appointing a vaccine skeptic to a leadership role. The decision triggered a firestorm of criticism from medical experts, lawmakers, and advocacy groups. Beyond the immediate controversy, the appointment reignited long-dormant ivermectin misinformation challenges...
The conversation around heart wellness in the United States is undergoing a major transformation as the latest hypertension U.S. guidelines push for early diagnosis, preventive action, and integrated care strategies. Hypertension remains a leading cause of cardiovascular disease, affecting nearly half of all American adults, according to national health data.
Amid...
In 2025, few healthcare issues have sparked as much political and public health debate as the push for OTC Ivermectin policy controversy 2025 USA in the United States. Once a relatively obscure antiparasitic drug, Ivermectin exploded into public awareness during the pandemic — fueled by social media claims about its potential benefits for Ivermectin...
New vaccine guidelines in 2025 have triggered widespread debate in the U.S., sparking renewed ivermectin conversations amid vaccine policy turmoil. As the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) adjust their stance on vaccine scheduling and coadministration, Americans find themselves divided not only over vaccines but also over alternative drugs...